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Abstract: The nanotechnology industry is currently in the process of producing new 
nanoparticles. The biological activity of nanoparticles including adverse as well as beneﬁ  cial 
effects tends to increase as their size decreases. The smaller the particles are, the greater their 
bioactivity and toxicity. Thus, one can easily conjecture the impact of a nanoparticle if it could 
also self-replicate. This in vitro study reveals the self-propagating ability of unique calcifying 
nanoparticles (CNP) that can be as small as 50 nm in size and found in blood, blood products, 
and calciﬁ  ed soft tissues. Although speciﬁ  c detection techniques, morphological characteristics 
and biomineralizing properties of CNP are well established, their genomic information and self-
propagating capability have always been challenged. The objective of this study is to document 
the propagation of CNP under physiological conditions, using inverted light microscopy (LM) 
and the Biostation IM time-lapse imaging system. Their detailed morphological structure was 
examined using scanning (SEM) and transmission (TEM) electron microscopy. This present 
study, in conjunction with previous ﬁ  ndings of metabolic activity, antibiotic sensitivity, antibody 
speciﬁ  city, morphological aspects and infectivity, validates CNP as self-replicators. Therefore 
these sterile-ﬁ  lterable, blood-borne nanoparticles should be of concern to the nanomedicine 
industry.
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Introduction
Nanotechnology is a rapidly evolving discipline that has aroused the interest of both 
the scientiﬁ  c community and the public. Ordinary materials such as carbon or silicon, 
when reduced to nanoscale level, often exhibit novel and unpredictable characteris-
tics such as extraordinary strength, resistance and chemical reactivity that the same 
material does not possess at the micro or macro-scale (Nel et al 2004). Although 
nanotechnology industry is very successful in manufacturing a variety of nanoparticles, 
they have yet to be successful in developing methods to eliminate them. Currently, 
sterile ﬁ  ltration is the most commonly used technique for biopharmaceutical products 
although it has no satisfactory capability of removing particles below 100 nm in size 
(Çiftçioglu et al 1997a).
The discovery of calcifying nanoparticles (CNP) in blood and blood products in the 
early 1990s resulted in a breakthrough in the ﬁ  eld of biology. CNP have been shown 
to be bacteria-like, pleomorphic, infectious particles that possess unique properties 
including the capability of passing sterilization ﬁ  lters because of their small size, and 
resistance to heat and γ-irradiation at doses typically fatal for conventional bacteria 
(Çiftçioglu et al 1997a, 1997b, 2007; Kajander et al 1997; Kajander and Çiftçioglu 
1998; Miller-Hjelle et al 2003). They deposit calcium and phosphate as an envelope 
at physiologic pH and mineral concentrations (Kajander and Çiftçioglu 1998; Miller-
Hjelle et al 2003). CNP has been associated with diverse calciﬁ  cation-related health 
problems such as arteriosclerosis, kidney stone, gall stone, dental pulp stone, prostatitis, International Journal of Nanomedicine 2008:3(2) 266
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Alzheimer’s, polycystic kidney, and cancer (Çiftçioglu et al 
1998a, 1998b; Kajander et al 1999; Kajander et al 2001; 
Puskas et al 2005; Altundag et al 2006; Shiekh et al 2006; 
Wang et al 2006; Wood and Shoskes 2006). CNP exert 
cytotoxic effects on some mammalian cells in vitro and in 
living organisms in vivo (Akerman et al 1997; Çiftçioglu 
and Kajander 1998).
Despite their potential role in major medical health 
problems (Kajander 2006), CNP could not be categorized 
under any group of infectious agents because of their unusual 
properties and lack of genomic information. Also, the self-
replicating nature of CNP has often been questioned (Cisar 
et al 2000). The terms “self-replication”, “self-assembly”, 
or “self-propagation” have been widely used for all systems 
including nanomachines, crystals, computer viruses, and 
memes (Freitas and Merkle 2004). Here we have investi-
gated the self-replicating ability of these medically important 
nanoparticles.
CNP have morphological changes in different culture 
conditions. For example they form excessive amounts of 
bioﬁ  lm when stressed with antibiotics, calcify less when cul-
tured in microgravity conditions and calcify profusely when 
serum/protein concentration is reduced below 5% (Bjorklund 
et al 1998; Kajander et al 2003; Çiftçioglu et al 2005). How-
ever their antigenicity remains the same, and they are still 
recognized by CNP-speciﬁ  c monoclonal antibodies (mAb) 
(Kajander et al 2003). Figure 1 shows a schematic diagram of 
the growth phases of CNP, cultured with and without serum 
containing medium. Starting at Stage A, in a serum contain-
ing medium, the tiny cell-like coccobacillar forms from the 
stock culture beginning to acquire thin coatings of apatite 
crystals on their organic membrane. They grow slightly larger 
in size as a result of this apatite accumulation (Stage B) and 
form dumbbell-shaped forms (Stage C). These forms can 
be passaged at 1/10 dilution for years and they continue to 
reproduce, maintaining the same shape and narrow size range 
(50–400 nm, Figure 1 i). The cycle from stages A to C and C 
to A can continue indeﬁ  nitely (Vali et al 2001). These small, 
coccobacillar CNP are referred to as serum-CNP (S-CNP) 
and this type of CNP is cultured when Dulbecco’s Modiﬁ  ed 
Eagle’s Medium (DMEM) is supplemented with 10% fetal 
bovine serum (FBS). However, if these S-CNP are passaged 
into serum (protein)-free media, the protein depletion causes 
CNP to produce bioﬁ  lm-like material and they attach to the 
surface of the culture vessel where they develop several apatite 
mineral layers around them (Figure 1 ii) forming “igloos” or 
“shells” (Figure 1 stages D–G, ii and iii) (Kajander et al 2003). 
These igloo forms harbor in their interior many S-CNP in a 
semi-dormant state, which can be observed only by using 
electron microscopy techniques (Çiftçioglu et al 1997b) 
(Figure 1 iv). We refer to these attached CNP igloos as serum-
free CNP (SF-CNP). We have SF-CNP cultures that have been 
passaged at 1/10 dilution monthly for over 17 years in serum 
and protein-free DMEM. So, the cycle from stages D to F and 
F to D can continue indeﬁ  nitely (as schematized in Figure 1). 
SF-CNP mineralize and grow larger in size (1–10 µm) when 
compared with S-CNP, as a result of calcium and phosphate 
deposition on their surface as shown in Figure 1 D–G, and 
ii–iv (Miller-Hjelle et al 2003).
The addition of the serum to the culture media brings 
the system back to Stage A. Many proteinaceous inhibitors 
of apatite crystal formation have been identiﬁ  ed in serum, 
which may account for the observed dissolution of the min-
eral layers (Garnett and Dieppe 1990). The SEM image in 
Figure 1 iv, and LM images in Figure 1: G1-G5 show how 
SF-CNP detaches from the surface and the apatite layers dis-
solve to release the S-CNP (50–100 nm) when serum/protein 
replenishment takes place.
The objective of this study is to document the 
propagation of both types of CNP under physiological 
conditions, using inverted LM and the BioStation IM 
time-lapse imaging system. While this optical microscopic 
imaging may seem like a simple technology, it is the only 
available technique of today for viewing the nanometer-
sized particles in real time.
Materials and methods
CNP cultures
In all experimental analyses we used the same CNP which 
was isolated from FBS (Sera Lab, Lot: 901045, Coun-
try; England), and deposited in German Bank DSM no. 
5819–5821. Two types of CNP (as described in Figure 1) 
were examined for the observation of self-propagation in 
speciﬁ  c culture conditions; subcultures of SF-CNP were 
conducted under strict aseptic conditions by passing a small 
inoculum (1/10 of a 3 week old culture) of SF-CNP into 
culture ﬂ  asks with fresh DMEM (Invitrogen, Carlsbad, CA, 
USA; supplemented with L-glutamine) under cell culture 
conditions (37 °C; 5%–10% CO2; 95% air at 90% humidity). 
For observation of S-CNP, the culture was passaged 1/50 into 
FBS-free DMEM. Therefore the ﬁ  nal serum concentration 
was reduced to 0.3% which caused S-CNP to attach to the 
culture vessel and make microscopic observations possible. 
As negative controls, DMEM with and without FBS (0.3%), 
and also inorganic hydroxyapatite crystals (Sigma-Aldrich, 
St Louis, MO, USA) in the two media, by omitting the International Journal of Nanomedicine 2008:3(2) 267
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Figure 1 Schematic diagram of the growth phases of CNP (cross-sectional view) cultured with and without FBS with corresponding SEM and LM images, and LM observation 
of dissolution of SF-CNP to S-CNP. A, B, and C are the forms of CNP in the presence of serum (S-CNP). (i): SEM image of S-CNP. D, E, and F are the forms of CNP in the 
absence of FBS (SF-CNP). (ii): LM image of apatite layers of SF-CNP. (iii): SEM image of the formation shown in (ii). G: Schema of SF-CNP when exposed to FBS, apatite layers 
dissolve releasing the S-CNP within 24 h. (iv): SEM image of phase G. G1–G5: A series of LM images showing the dissolution of SF-CNP apatite layers and clumps of S-CNP 
released, with the replenishment of FBS. Bars: (i) = 100 nm; (ii) = 5 µm; (iii) = 2 µm; (iv) =1 µm; (G1–G5) = 5 µm.
Abbreviations: CNP, calcifying nanoparticles; FBS, fetal bovine serum; LM, light microscopy; SEM, scanning electron microscopy. 
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CNP addition step were incubated under the same culture 
conditions and culture period. All cultures were observed 
with microscopy for 3 weeks and were not re-fed with fresh 
medium for the entire duration of the experiment. At the end 
of experiment, cultures were passed through quality control 
tests checking for conventional bacteria contamination, and 
CNP epitope positivity using the double staining technique 
as described earlier (Kajander and Çiftçioglu 1998). The 
Double staining technique is a combination technique of 
immunoﬂ  uorescence staining with CNP-speciﬁ  c mAb 8D10 
(Nanobac, OY), and Hoechst (#33258) ﬂ  uorochrome staining 
(Kajander et al 2003).
Microscopy and photography
Two types of imaging were performed: a) using the conven-
tional inverted LM (Nikon, Eclipse TE2000-U) in the phase 
contrast mode and b) imaging using Nikon’s BioStation IM 
(Nikon Instruments Inc., Melville, NY).
For observation of SF-CNP replication with the 
conventional LM, objectives with 20X and 60X, eyepiece 
with 10X, and an intermediate optics of 1.5X magniﬁ  cations 
were used. The culture ﬂ  asks were indexed with a diamond 
pen so as to view the same ﬁ  eld. Each time the same focus 
planes were located using the 2 magnifications: 300X 
and 900X. Images were captured digitally using Nikon’s 
charged-coupled device camera (Digital Sight DS-L1). A 
few large CNP were marked 1–4 (with arrows) on the images 
(Figure 2) in order to identify the same spots throughout the 
observation.
BioStation IM is a time-lapse imaging system on loan 
to us from Nikon, so we only had time for a limited set of 
time-lapse experiments. This microscopy system is a novel 
compact cell incubation and monitoring system allowing 
time-lapse cell imaging without the set-up and alignment 
complexity of conventional time-lapse imaging systems. The 
system combines an incubator that maintains mammalian cell 
culture conditions, a microscope with a numerical aperture of 
NA 0.80, delivering high resolution images in phase-contrast 
mode, an internal motorized stage supporting X, Y, and Z 
dimensional movement with reduced focus-drift, and a high 
performance CCD digital imaging camera for capturing time-
lapse image sequences (see http://www.nikonusa.com). Both 
S-CNP and SF-CNP were monitored in 30 mm cover-slip 
bottom petri-dishes under 40X magniﬁ  cation. Time-lapse 
imaging was conducted for 5 days with images taken at 
regular intervals. The exposure time was 1/10sec, at 1600 × 
1200 pixel resolution. Both S-CNP and SF-CNP counts were 
performed using ImageJ software (NIH, USA).
For SEM, at the end of the experiments, the cultures 
were either scraped with a cell culture scraper, harvested by 
centrifugation (Mikro22R, Hettich, Germany) at 14,000 g 
for 20 min, and using the pellet as a sample, or a piece of 
culture vessel having attached CNP was cut with a heated 
scalpel and used in the sample preparation. The samples were 
washed twice with phosphate buffered saline, pH 7.4 (PBS) 
and ﬁ  xed with 2% gluteraldehyde in PBS for 16 h at 4 °C. The 
ﬁ  xed samples were washed twice with PBS, dehydrated with 
gradually increasing ethanol concentrations, and dried with a 
critical point dryer (Çiftçioglu et al 2002). The samples were 
coated with gold (thickness, 20 to 40 nm) prior to examina-
tion with a JEOL 5910LV SEM (Jeol Ltd., Tokyo, Japan) 
with attached energy dispersive spectroscopy (EDS).
For TEM, SF-CNP cultures were harvested, ﬁ  xed with 
formaldehyde-gluteraldehyde mixture, epoxy-embedded, 
and sectioned as described earlier (Kajander and Çiftçioglu 
1998). For S-CNP cultures, negative staining is applied 
and observed under TEM (JEOL 2000FX, Tokyo, Japan) 
(Çiftçioglu and Kajander 1998).
Results
For our initial set of experiments we used only SF-CNP. 
Figure 2 shows optical microscopic images of culture follow 
up of SF-CNP over a period of 25 days. Coccoidal particles 
(1 µm) were observed which attached to the culture vessels 
by the end of ﬁ  rst day incubation. These particles are the 
S-CNP released from the main culture during passaging. 
Figure 3 shows igloo-shaped SF-CNP by SEM and TEM 
after they are detached from the culture ﬂ  ask. On the ﬁ  rst 
day of the SF-CNP culture, both small- and larger-sized, 
igloo-shaped formations were observed in small number. 
Appearance of small particles around the large coccoid 
cells is seen from Day 2 (Figure 2B). Over time the particles 
become more visible, optically opaque, and bigger due to 
apatite deposition. In this experiment, we observed that CNP 
grow within a size range between 0.5–6 µm and apparently 
increase in number.
Using Nikon’s BioStation IM imaging system, both 
SF and S-CNP were imaged for a period of 5 days each. 
Although this culture period is short, we see an increase in 
number in both types of CNP (Figures 4 and 5). The results 
obtained were comparable with that from the previous 
experiment using inverted LM. A graph of SF-CNP count 
against time was plotted (Figure 4D). The total culture 
period was 120 h. The graph indicates a linear increase in 
SF-CNP number with time. Time-lapse imaging of S-CNP 
shows a gradual increase in their number over a period of International Journal of Nanomedicine 2008:3(2) 269
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5 days (Figure 5). Preliminary studies over shorter time 
periods showed that replication was reproducible between 
runs (data not shown). For all the experiments conducted, 
negative controls without any CNP in DMEM, with and 
without FBS, did not show any particle formation or growth 
(data not shown). EDS showed Ca and P peaks in both forms 
of CNP (Figure 6). Also, negative controls with inorganic 
hydroxyapatite in similar media and culture conditions, did 
not show any increase in the apatite particle number or size 
(data not shown).
Interestingly, we observed similar propagation character-
istics in both S-CNP and SF-CNP. The results of TEM and 
Figure 2 Optical micrograph of SF-CNP showing an increase in number over a culture period of 25 days. (A) Day 1 at 900X magniﬁ  cation; (B–E) Days 2, 5, 10, and 25, 
respectively at 300X magniﬁ  cation. The white arrows in each image indicate the same large SF-CNP on the same spot throughout the experiment. (F) measurements of a few 
SF-CNP on Day 25 at 900X magniﬁ  cation. All particles seen in the images are the different sizes of SF-CNP. Bars: (A) = 15 µm; (B), (C), (D), and (E) = 30 µm; (F) = 5 µm.
Abbreviation: SF-CNP, serum-free calcifying nanoparticles.
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SEM analyses of both types of CNP showed spherical and 
semi-spherical particles with rough surface and budding-like 
structures (Figures 3 and 7) despite their difference in size 
and thickness of apatite envelope.
Discussion
In nanotechnology, in all nanoparticle production processes 
and applications, there is potential for exposure. Current 
methods for quality certiﬁ  cation of high efﬁ  ciency particulate 
air (HEPA) ﬁ  lters, respirator ﬁ  lters, and ﬁ  lters for biological 
processes do not routinely require testing particle sizes below 
100 nm. CNP is a good example of a blood-borne agent 
capable of passing ﬁ  ltration barriers with their exception-
ally small size.
Critics have proposed CNP to be protein or crystal 
precipitates rather than a self-propagating agent (Cisar et al 
2000; Vali et al 2001). To eliminate this possibility we 
conducted our study with serum-free culture media under 
physiological conditions. Also, the absence of serum in 
medium allowed the CNP to attach to the surface of the 
culture dish, facilitating their observation with LM over 
a prolonged time period. In our experiments, as negative 
controls, we used culture media with and without FBS 
(0.3%) and incubated them in the absence of CNP under 
similar culture conditions and culture period as CNP cultures. 
We have not observed any protein precipitation or crystal 
formation in the negative controls (data not shown).
In previous studies, the S-CNP doubling rate has been 
calculated as a mean value of 72 hours with a logarithmic 
increase in turbidity in cultures with lag and log growth 
phases (Çiftçioglu et al 1997b). In this study, since the S-CNP 
were passaged into SF media, they attached themselves to the 
culture dish. Hence, measurement of turbidometric changes 
for these attached CNP was not possible. It has also been 
reported that for SF-CNP the growth rate is even slower 
(Çiftçioglu et al 1997b).
Previous time-lapse studies of crystal growth have shown 
sedimentation of microcrystals onto the larger crystals with 
formation of defects (Malkin et al 1996; Piana et al 2005). 
Also, for crystal growth to occur, supersaturated conditions 
are required at least during preliminary stages (Goe 1976; 
Fosythe et al 1994; Vali et al 2001). CNP self propagates 
under physiological conditions. For more than a decade, 
CNP have been cultured and passaged under physiological 
conditions similar to mammalian culture conditions, without 
any change in their growth characteristics and specific 
monoclonal antibody recognizing epitopes (Çiftçioglu et al 
2006). Inorganic apatite under similar conditions, do not show 
any growth or other characteristics as shown in Table 1.
The exact mechanism by which apatite is nucleated and 
formed around CNP is unknown. However, when serum or 
protein concentration is reduced (5%) in the CNP culture, 
they start to mineralize and grow larger in size, forming 
“igloo” like structures due to calcium and phosphate deposi-
tion on their surface as conﬁ  rmed by EDS analysis (Figure 6). 
As seen in SEM Figure 1-iii, these igloos can reach up to 
several microns thick, sheltering within them tiny nanome-
ter-sized CNP. Within their apatite shelter, CNP continue to 
Figure 3 Electron microscopic images of SF-CNP. (A) SEM of an empty apatite “igloo” detached from the culture medium. (B) TEM section of a similar SF-CNP and its inner 
structure. Arrows point to the apparently budding side of the shell. Bars: (A) =1 µm; (B) = 500 nm.
Abbreviations: SEM, scanning electron microscopy, SF-CNP, serum-free calcifying nanoparticles; TEM, transmission electron microscopy.
B AInternational Journal of Nanomedicine 2008:3(2) 271
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Figure 4 Time-lapse imaging and plot of SF-CNP from Day 0 to Day 5 using Nikon’s BioStation IM. Only a few intermediate images of SF-CNP on Days 0, 3, and 5 at 40X 
magniﬁ  cation are shown. The white arrows mark some large SF-CNP on the same spot throughout the experiment. Note the small SF-CNP within the square blocks showing 
an increase in size and number over time. A graph of SF-CNP count against time in hours shows a linear increase in the SF-CNP number. The images and graph together imply 
an increase in size and number of SF-CNP over a period of 5 days. Bars: (A), (B), and (C) = 15 µm.
Abbreviation: SF-CNP, serum-free calcifying nanoparticles.
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Figure 5 Time-lapse imaging and plot of S-CNP from Day 0 to Day 5 using Nikon’s BioStation IM. Only a few intermediate images of S-CNP on Days 0, 2, and 5 at 40X magniﬁ  cation 
are shown. The black arrows point to some S-CNP on the same spot throughout the experiment. Bars: (A), (B), and (C) = 15 µm.
Abbreviation: S-CNP, serum calcifying nanoparticles.
grow but at a slower rate, in a semi-dormant state, and are 
released from their igloos when serum/protein is replenished 
(Figure 1-iv). This characteristic of CNP enables them to 
survive in body ﬂ  uids as free nanometer-sized particles and 
also as thick plaques in calciﬁ  ed soft tissues.
Binary ﬁ  ssion is the usual form of reproduction by bacteria, 
although a few bacteria and some eukaryotes (including 
yeasts) replicate by budding (Angert 2005). In environmental 
microbiology, it is known that there are aquatic microorganisms 
that use both binary division and budding mechanism while 
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Ca P O
Si
Figure 7 TEM image of “dividing” S-CNP. (A) Unique septa-like divisions (“cells” 
on the right, with white-small arrows). (B) A unique inner structure of CNP during 
division. Thick white arrows show budding-like formations, black arrows show dark 
stained apatite layer on the surface of CNP. Bars: 50 nm.
Abbreviations: CNP, calcifying nanoparticles; S-CNP, serum calcifying nanoparticles; 
TEM, transmission electron microscopy.
Figure 6 EDS analysis of CNP apatite. Si peak is because of the glass substrate on 
which CNP samples were cultured.
Abbreviations: CNP, calcifying nanoparticles; EDS, energy dispersive spectroscopy. 
Table 1 Comparison of two self-replicators: CNP and inorganic apatite crystals
Properties CNP Inorganic apatite crystals
Culture in DMEM under 
mammalian cell culture 
conditions
Increase in number (Çiftçioglu et al 1997) No increase in number and size 
(Çiftçioglu et al 1997)
Size Very narrow range (Kajander et al 1997; 
Çiftçioglu et al 1997)
S-CNP: 80–500 nm 
SF-CNP: 0.5–10 µm 
Very wide range
2 nm to centimeters or more 
Ultramicroscopic morphology Always have closed membranous vesicles involved 
with budding-like or septa-like formations 
(Kajander et al 1997; Çiftçioglu et al 1997)
No “cell like” structure 
Chelation with EDTA or acids Release and precipitation of organic matter 
(Çiftçioglu and Kajander 1999; Kumar et al 2006)
Dissolves totally without any residue 
(Kumar et al 2006)
Antibiotic/chemotherapeutic 
effect on cultures
Sensitive to tetracycline, aminoglycosides, nucleic 
acid synthesis inhibitors, bisphosphonates, etc 
(Çiftçioglu et al 2002; Kajander et al 2003; 
Kumar et al 2006)
No effect (Kajander et al 2003; 
Çiftçioglu et al 2002; Kumar et al 2006)
Metabolic labelling 
(S-methionine, uridine)
(+) (Kajander et al 1997; Miller et al 2004) (−)
Recognition by monoclonal 
antibody for CNP (8D10)
(+) (Çiftçioglu and Kajander 1998) (−)
Infectivity + (Increased antibody level) (Çiftçioglu et al 2007) - No immune response 
Adaptation to physiological 
condition (morphological 
changes with protein concen-
tration, antibiotics, heat)
(+) (Bjorklund et al 1998; Çiftçioglu and Kajander 
1999; Çiftçioglu et al 2002, 2005)
No effect (Çiftçioglu and Kajander 
1999; Kumar et al 2006) 
Stainability with pico-green, 
ribo-green, and Hoechst
(+) (Kumar et al 2006) (−)
When injected intravenously to 
the rabbits
Goes to kidney (Akerman et al 1997) No speciﬁ  c organ (Donaldson and 
stone 2004)
Polarized light treatment Reduces bioﬁ  lm formation (Sommer et al 2002) No response (Kajander et al 2003; 
Sommer et al 2002)
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they are self-propagating (Angert 2006). Figures 3 and 7 are 
electron microscopic images of CNP showing both ﬁ  ssion and 
budding-like, division-like formations.
The metabolic potential of CNP was conﬁ  rmed using 
a tetrazolium salt detecting dehydrogenase activity, and 
S-methionine incorporation (Kajander et al 1997; Kumar et al 
2006). Also, ß-mercaptoethanol, known to enhance growth 
of certain microorganisms and mammalian cells, promoted 
CNP metabolism and growth (Kumar et al 2006). Polarized 
light was shown to reduce CNP bioﬁ  lm formation indicating 
a light induced metabolic process within CNP (Sommer et al 
2002). Apparently CNP have metabolic activity which clearly 
differentiates them from inorganic crystal formation. It is 
obvious that these CNP manifest various functions besides 
self-replication, using an unidentiﬁ  ed set of instructions 
originating from within their system.
Regardless of all the peer reviewed and published 
scientiﬁ  c literature related to CNP growth, antigenicity, 
infectivity and medical impact over the past 15 years, a 
controversy has continued to surge regarding the signiﬁ  cance 
of CNP. However, it is also known that any uncharacter-
ized nanoparticle in any biopharmaceutical product should 
be of concern. Nanoparticle toxicology concerns include 
translocation to the brain, general effects to the blood vessel 
wall and coronary artery disease (Donaldson 2006). CNP 
have been linked to many pathological calciﬁ  cation related 
diseases (Çiftçioglu et al 2006) and exert cytotoxic effects 
on some mammalian cells (Çiftçioglu and Kajander 1998; 
Akerman et al 1997). CNP are commonly present in bovine 
blood and thus in cell culture products, including vaccines 
and gammaglobulin (Çiftçioglu et al 1997). Our study was 
conﬁ  ned to pure CNP cultures. When CNP is present in 
blood circulation, they may bind protein and other blood 
components to their surface and increase the complexity 
of replication.
In the ﬁ  eld of nanomedicine, nanoparticles are being 
developed for use in imaging and therapy (Freitas 2005). 
Medicinal nanoparticles are being designed similar to bio-
logical molecules so that they are biodegradable (Ebbesen 
and Jensen 2006). However, the very properties that make 
nanoparticles useful for new applications are also the very 
properties that make them harmful (SooChoi et al 2007). 
The surface charge of a nanoparticle determines as to what 
it can adsorb, penetrate, or adhere to (Nel at al 2006; Jallouli 
et al 2007; Ludlow 2007). CNP with their apatite envelope 
have been found to induce immune response against proteins 
adhered to them (Çiftçioglu et al 2007). Hence, caution 
must be exercised in the use of apatite nanoparticles or any 
other ﬁ  ne grain particles for vaccination, drug delivery, or 
cosmetics.
Conclusions
In this study we demonstrated the self-propagation of CNP, 
originally discovered in biopharmaceutical products, and 
the only blood-borne, nanometer-sized particles that have 
been correlated with several pathological calciﬁ  cations. It is 
possible for nanoparticles to pass into biological products, 
remain undetected, and cause major health problems.
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